INCLUDE

Better Healthcare Through More Inclusive Research

Background

In 2017, the National Institute for Health Research Clinical Research Network executive team commissioned a project to improve the inclusion of under-served groups into clinical research. Since then we have had a series of scoping reviews, surveys and stakeholder events. All that input is set out into a road-map to steer development of guidance and initiatives to help include under-served groups in research.

INCLUDE provides a suggested framework of questions to guide the deliberations of funders, researchers and delivery teams as they design and assess clinical research proposals. It gives examples of good practice and resources to guide teams seeking to engage with, and include under-served groups in clinical research.

This guidance from the NIHR INCLUDE Project makes recommendations and suggestions for how under-served groups can be more successfully included in COVID-19 research. These cover research priority setting; funding bodies strategic priorities; research investigator questions; initial design and funding; final study design; study delivery; study closure and analysis; and impact, dissemination and engagement.

Video: Including under-served groups in COVID-19 research

This is an introduction to including Under-served groups in COVID research by Professor Miles Witham, National Lead for the Ageing Specialty Group

This article is about developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process

This guidance from the NIHR INCLUDE Project summarises what an under-served group is, provides a roadmap suggesting intervention points to improve inclusion, examples of under-served groups and example barriers to inclusion. It offers a suggested framework of questions to guide the deliberations of funders, researchers and delivery teams as they design and assess clinical research proposals, and ends with examples of good practice and other resources to guide teams seeking to engage with, and improve inclusion of, under-served groups in clinical research.